Roche's So­phie Ko­rnows­ki joins Chris Viehbach­er at Gur­net Point; FDA will give Roche's ground­break­ing flu drug speedy re­view

→ We now know where So­phie Ko­rnows­ki is head­ed. The top deal­mak­ing ex­ec at Roche left re­cent­ly, leav­ing James Sabry with a chance to move up to the ex­ec­u­tive com­mit­tee as he com­bines the busi­ness teams at Roche and its big sub­sidiary Genen­tech. Now we’ve learned that Ko­rnows­ki is join­ing ex-Sanofi CEO Chris Viehbach­er at Gur­net Point Cap­i­tal. She’ll now con­cen­trate on build­ing up the port­fo­lio with Ernesto Bertarel­li’s in­vest­ment mon­ey.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER